ResearcherKanazawa UniversityNo recent work listed
Yao Hua Song
Matched on ORCID iD 0000-0003-0025-795X; OpenAlex author ID A5101874767. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation. Co-author DOI 10.3390/cancers15051480↗
- IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer. Co-author DOI 10.1016/j.prp.2019.152650↗
- Gemcitabine induces cell senescence in human pancreatic cancer cell lines. Co-author DOI 10.1016/j.bbrc.2016.06.063↗
- MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine. Co-author DOI 10.18632/oncotarget.3885↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Naofumi Mukaida · 3 shared papers, 2015–2019 · strength 0.25
- Paper IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer. DOI 10.1016/j.prp.2019.152650↗
- Paper Gemcitabine induces cell senescence in human pancreatic cancer cell lines. DOI 10.1016/j.bbrc.2016.06.063↗
- Paper MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to ge… DOI 10.18632/oncotarget.3885↗
- Lei Wang · 1 shared paper, 2023 · strength 0.24
- Pengcheng Zhou · 1 shared paper, 2023 · strength 0.24
- Yuhua Lu · 1 shared paper, 2023 · strength 0.24
- Hua Huang · 1 shared paper, 2019 · strength 0.11
- Ying-Yi Li · 1 shared paper, 2015 · strength 0.05
- Chen Liang · 1 shared paper, 2015 · strength 0.05
- Hongyu Li · 1 shared paper, 2015 · strength 0.05
- Zhen Wang · 1 shared paper, 2015 · strength 0.05
- Xianjun Yu · 1 shared paper, 2015 · strength 0.05
- Xiaozhong Guo · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.